Ceramide-1-phosphate activates cytosolic phospholipase A2α directly and by PKC pathway


    loading  Checking for direct PDF access through Ovid

Abstract

Ceramide-1-phosphate (C1P), a novel bioactive sphingolipid, is implicated in the vital cellular processes such as cell proliferation and inflammation. The role of C1P on activity of cytosolic phospholipase A2α (cPLA2α), a key enzyme for the release of arachidonic acid (AA) and prostanoids, has not been well elucidated. In this study, we investigated the effect of C1P on the release of AA from L929 cells and a variant, which lacks cPLA2α expression, C12 cells. C1P at 30 μM alone induced AA release from L929 cells without an increase in intracellular Ca2+ concentration. C1P-induced AA release was marginal in C12 cells, and treatment with an intracellular Ca2+ chelator (BAPTA-AM) or an inhibitor of cPLA2α (2 μM pyrrophenone) decreased C1P-induced AA release in L929 cells. C1P increased the enzymatic activity of cPLA2α over two-fold in the presence of Ca2+. C1P triggered the translocation of cPLA2α and its C2 domain from the cytosol to the perinuclear region in CHO-K1 cells. Interestingly, C1P at 10 μM synergistically enhanced ionomycin-induced AA release from L929 cells. The AA release induced by C1P with and without ionomycin decreased by treatment with protein kinase C (PKC) inhibitor (10 μM GF109203X) and in the PKC-depleted cells. C1P at 10 μM stimulated the translocation of PKC (α and δ) from the soluble to the membrane fractions. We propose that C1P stimulates AA release via two mechanisms; direct activation of cPLA2α, and the PKC-dependent pathway.

    loading  Loading Related Articles